plat

(redirected from Reteplase)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.
Related to Reteplase: Tenecteplase

plat

A plan or survey map of a parcel of land.Developers file subdivision plats showing block and lot numbers, the dimensions and locations of individual lots, and the dimensions and locations of dedicated streets. Legal descriptions for properties within the subdivision are then made by reference to the recorded plat,such as “Lot 2,Block 3 of Harper Downs II as recorded in Plat Book 213,Page 82, of the Judge of Probate of Jefferson County,Alabama.”

The Complete Real Estate Encyclopedia by Denise L. Evans, JD & O. William Evans, JD. Copyright © 2007 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
Of total patients, 345 (83.3%) were thrombolysed by streptokinase, and 69 (16.7%) by reteplase (Table 1 and Figure 2).
Studies on reteplase with abciximab provided optimistic results regarding the possibility of increasing reperfusion after AIS.
Conclusion: The oxidizing cytoplasm of Rosetta-gami and Shuffle T7 in addition to alterations of cultivation parameters could not result in soluble production of reteplase, although the inclusion bodies produced in these two strains might increase the rate of refolding procedure likely due to formation of folding intermediates.
Sayah et al., "Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of the early retavase-thrombolysis in myocardial infarction (ER-TIMI) 19 trial," Journal of the American College of Cardiology, vol.
Samples treated with streptokinase, tenecteplase, and reteplase did not yield a sufficient number of quality metaphases (less than 20 metaphases) for routine clinical analysis.
The efficacy of reteplase in the treatment of thrombosed hemodialysis venous catheters.
Reteplase, which also has a high molecular weight, treats acute MI and is not teratogenic in animals but was an abortifacient in rats and rabbits.
Cardiologists typically treat heart attacks with either thrombolytic drugs, such as reteplase, to dissolve offending clots, or primary angioplasty, to clear the plaque producing the heart attack.
Reteplase has no carbohydrate side chains and thus can be produced in E.
Similarly, Qureshi, Suri, Geogiadis, Vazquez, and Janjua (2009) performed a pool of four prospective studies to evaluate the following IA recanalization techniques: (a) IV rtPA and mechanical clot disruption with an Amplatz gooseneck microsnare, (b) IV Abciximab and IA Reteplase, (c) EKOS MicroLys infusion catheter, and (d) IA Reteplase and mechanical clot disruption with an Amplatz gooseneck microsnare, paying close attention to the following three factors: the effect of age of 80 years or older on angiographic recanalization, good outcomes as evidenced by mRS score, and rate of mortality at 1-3 months.
Following the stabilization with a pacing wire, the patient was thrombolyzed with intravenous reteplase (10 units + 10 units, 30 minutes apart), followed by unfractionated heparin infusion (5000 units bolus + 1000 units/hour infusion).
So far, a variety of thrombolytic drugs have been used: tenecteplase (TNKase), reteplase (Retavase), alteplase (Activase), and urokinase.